Home > Insider Trading > Filing (0001562180-25-000615)

Filing Details

Accession Number:: 0001562180-25-000615
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-28 16:30:25
Reporting Period:: 2025-01-27

Accepted Time:: 2025-01-28 16:30:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673232	Michael Benkowitz	C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910	President And Coo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-01-27	7,500	$111.00	7,500	No	4	M	Indirect	By Trust
Common Stock	Disposition	2025-01-27	4,147	$369.54	3,353	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	1,009	$370.54	2,344	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	544	$371.52	1,800	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	1,000	$372.41	800	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	700	$373.62	100	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	100	$375.22	0	No	4	S	Indirect	By Trust
Common Stock	Acquisiton	2025-01-27	2,500	$111.00	2,500	No	4	M	Indirect	By Trust
Common Stock	Disposition	2025-01-27	1,395	$369.70	1,105	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	405	$371.09	700	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	500	$372.66	200	No	4	S	Indirect	By Trust
Common Stock	Disposition	2025-01-27	200	$373.99	0	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	M	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2025-01-27	7,500	$0.00	7,500	$111.00
Common Stock	Stock Options	Disposition	2025-01-27	2,500	$0.00	2,500	$111.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,179	2021-03-15	2028-03-15	No	4	M	Indirect
14,500	2021-03-15	2028-03-15	No	4	M	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,577	Direct

Footnotes

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 7, 2024.
This transaction was executed in multiple trades at prices ranging from $370.69 to $371.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $372.21 to $373.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and haveshared investment and voting power.
This transaction was executed in multiple trades at prices ranging from $369.08 to $370.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $370.09 to $371.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $371.09 to $372.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $372.09 to $372.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $373.16 to $373.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
This transaction was executed in multiple trades at prices ranging from $369.49 to $370.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.